Cerluten — EU research guide.
Cerluten is a synthetic tripeptide (Peptide complex (cytomedine)) from the Khavinson bioregulator series proposed to act on nervous system gene regulation. It sits in the same family as Pinealon, which PeptideCompare already tracks, and is frequently discussed alongside it in Eastern European longevity research protocols.
What is Cerluten?
Cerluten is a synthetic tripeptide (Peptide complex (cytomedine)) from the Khavinson bioregulator series proposed to act on nervous system gene regulation. It sits in the same family as Pinealon, which PeptideCompare already tracks, and is frequently discussed alongside it in Eastern European longevity research protocols.
What does the research show?
Available data centers on neuronal gene-expression studies and aged-animal models, with claims of supporting nervous-system aging resilience. As with other Khavinson bioregulators, independently replicated human clinical trial data is not publicly available as of mid-2026.
EU legal status
Not approved as a medicine anywhere in the EU. Available from a small number of specialist research peptide vendors for laboratory use only.
Molecular information
Pharmacokinetics
Cerluten is not yet in our price comparison
We expand EU supplier coverage every month.